Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference104 articles.
1. Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;355(12):1233–43.
2. Hillmen P, Hall C, Marsh JCW, Elebute M, Bombara MP, Petro BE, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2004;350(6):552–9.
3. US Food and Drug Administration (FDA). Clinical pharmacology and biopharmaceutics review. Silver Spring: US FDA; 2007.
4. Ricklin D, Mastellos DC, Reis ES, Lambris JD. The renaissance of complement therapeutics. Nat Rev Nephrol. 2018;14(1):26–47.
5. European Medicines Ageny (EMA). CHMP extension of indication variation assessment report. London: EMA; 2017.
Cited by
91 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献